Swiss Innovation Challenge

October 25, 2019

KetoSwiss achieved 5th place at the Swiss Innovation Challenge. For more information please visit http://www.swissinnovationchallenge.ch/

Dr. Adrian Soto joins KetoSwiss AG

July 19, 2019

We are excited to welcome Dr. Adrian Soto to our team at KetoSwiss AG. Adrian joins the firm as Chief Medical Officer. Welcome!

Final product (MigraKet4) developed

July 18, 2019

Looking back at 4 years of development, KetoSwiss AG has finalised its product. In a next step, clinical trials will be conducted - we keep you posted.

Dr. Sebastian Hersberger joins KetoSwiss AG

June 1, 2019

The KetoSwiss team is enriched by Sebastian, an expert in business development and financial management, who joins KetoSwiss AG as Chief Operating Officer. Welcome!

KetoSwiss extents its portfolio to Alzheimer's

February 18, 2019

In addition to migraine, KetoSwiss will clinical test  the efficacy of its lead product in Alzheimer's Disease with the first randomised controlled trial starting in summer 2019.

First pharmacokinetic trial completed

January 16, 2019

The first PK trial on healthy subjects has been completed, the second is starting soon.

KetoSwiss completes Seed Funding round

October 14, 2018

KetoSwiss raised CHF 0.5 million in a first seed funding round.